Ubiquitin Ligase Drug Discovery Conference to Take Place June 24-25 in San Diego, CA.

Twenty leading industry and academic researchers will present their latest research developments in the field of ubiquitinylation at a new conference entitled, "Targeting Ubiquitinylation for Drug Discovery," in San Diego, CA on June 24-25, announces Strategic Research Institute.

San Diego, CA, April 12, 2002 /PRNewswire/ --

Twenty leading industry and academic researchers will present their latest research developments in the field of ubiquitinylation at a new conference entitled, "Targeting Ubiquitinylation for Drug Discovery," in San Diego, CA on June 24-25, announces Strategic Research Institute.

The meeting will be broken into four discrete sections: 1) Identification & Validation of Ubiquitin Ligases, 2) Novel Targets for Drug Discovery, 3) Structure & Function of Ubiquitin Ligases, and 4) Emerging Technologies.

Featured academic presentations include:

"Roles of the Proteasome in Normal and Disease States," Alfred Goldberg, Ph.D., Harvard Medical School

"Control of Cell Proliferation by SCF Ligases," Michele Pagano, Ph.D., New York University

"Structure-function Analysis of E3 Ubiquitin Ligases," Tony Hunter, Ph.D., Salk Institute

Scientific presentions by industry will be given by Pharmacia, Millennium Pharmaceuticals, Regeneron Pharmaceuticals, Roche Bioscience, Celgene Signal Research Division, GPC Biotech, Cognia, DiscoveRx, Enanta, OsteoScreen, Rigel, Triad Therapeutics, and Zymed Laboratories. Academia will be represented by Cornell Medical Center, Harvard Medical School, Mount Sinai, New York University, Salk Institute, Scripps Research Institute, and the University of Texas.

To receive the full agenda, and/or register for the conference, please contact Jon E. Liong of Strategic Research Institute at jliong@srinstitute.com or 212-967-0095, x243 (please include name, corporate affiliation, mailing address, and fax number).

For more information on exhibiting opportunities, or to register as a sponsor please contact Mark Alexay at malexay@srinstitute.com.

Jon E. Liong
Producer, Pharmaceutical Division
Strategic Research Institute
212-967-0095, ext. 243
jliong@srinstitute.com
www.srinstitute.com